Asceneuron Appoints Peter Van Vlasselaer as Chairman PR Newswire LAUSANNE, Switzerland and CAMBRIDGE, Ma., January 17, 2019 LAUSANNE, Switzerland and CAMBRIDGE, Ma., January 17, 2019 /PRNewswire/...
Lilly Completes Acquisition of ARMO BioSciences PR Newswire INDIANAPOLIS, June 22, 2018 INDIANAPOLIS, June 22, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the...
WeissLaw LLP: ARMO BioSciences Inc. Acquisition May Not Be In The Best Interests of ARMO shareholders PR Newswire NEW YORK, May 14, 2018 NEW YORK, May 14, 2018 /PRNewswire/ -- WeissLaw LLP is...
Shares of health-care companies rose as deal activity lured investors back into the biotech sub sector. In the latest sign that Big Pharma is optimistic about the prospects of immunotherapy cancer...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of ARMO BioSciences, Inc. PR Newswire NEW YORK, May 10, 2018 NEW YORK, May 10, 2018 /PRNewswire/ -- Rowley Law PLLC is investigating...
By Austen Hufford Eli Lilly and Co. is buying ARMO BioSciences Inc. for $1.6 billion, the latest investment in the hot area of immunotherapy cancer treatments. Immunotherapy, or immune-cell...
ARMO BioSciences Alert: Johnson Fistel Investigates Proposed Sale of ARMO BioSciences, Inc.; Is $50 a Fair Price? PR Newswire SAN DIEGO, May 10, 2018 SAN DIEGO, May 10, 2018 /PRNewswire/...
Lilly Announces Agreement To Acquire ARMO BioSciences $1.6 billion transaction will bolster Lilly's clinical portfolio with ARMO's lead immuno-oncology asset, pegilodecakin, which is being...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.